FDA Inspection 992394 — AndersonBrecon, Inc. D.B.A. PCI Of Illinois
The FDA completed an inspection of AndersonBrecon, Inc. D.B.A. PCI Of Illinois on Nov 1, 2016 in Rockford, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 1, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rockford, IL (United States)